Xerostomia (Dry Mouth) Caused by Radiation Therapy

What is Xerostomia (Radiation Therapy)?

Xerostomia, commonly known as dry mouth, is the sensation of insufficient saliva in the mouth. When it occurs after radiation therapy, it is usually the result of damage to the salivary glands that are located near the head‑and‑neck region. Saliva plays crucial roles in chewing, swallowing, speaking, protecting teeth from decay, and maintaining the health of the oral mucosa. A reduction in saliva can therefore profoundly affect nutrition, speech, oral hygiene, and overall quality of life.

Radiation‑induced xerostomia is most often seen in patients receiving treatment for cancers of the head and neck (e.g., oral cavity, oropharynx, nasopharynx, thyroid, and nasopharyngeal lymphoma). The severity of dry mouth depends on the total radiation dose, the fractionation schedule, and whether advanced techniques such as intensity‑modulated radiation therapy (IMRT) are used to spare the salivary glands.

According to the Mayo Clinic, up to 80 % of patients receiving >50 Gy to the parotid glands develop clinically significant xerostomia.

Common Causes

While this article focuses on radiation‑related xerostomia, many other conditions can also result in a dry mouth. The most frequent contributors are:

• Radiation therapy to the head and neck – direct damage to the parotid, submandibular, and sublingual glands.
• Chemotherapy agents – especially anticholinergic drugs, cyclophosphamide, and cisplatin.
• Medications – antihistamines, antidepressants, antipsychotics, diuretics, and muscle relaxants.
• Sjögren’s syndrome – an autoimmune disease that attacks salivary and lacrimal glands.
• Systemic diseases – diabetes mellitus, rheumatoid arthritis, and HIV infection.
• Neurological disorders – Parkinson’s disease, stroke, or cerebral palsy affecting autonomic control.
• Dehydration – from inadequate fluid intake, fever, vomiting, or diarrhea.
• Salivary gland obstruction – salivary stones (sialolithiasis) or tumors.
• Tobacco and alcohol use – chronic irritation reduces saliva production.
• Age‑related changes – salivary flow naturally declines with aging.

Associated Symptoms

Patients with radiation‑induced xerostomia often experience a constellation of oral and systemic symptoms, including:

• Difficulty chewing, swallowing, or forming a cohesive bolus of food.
• Altered taste (dysgeusia) or a persistent metallic/ bitter flavor.
• Increased dental decay (radiation caries) and gum disease.
• Oral mucosal inflammation, ulcerations, or fungal infections (candidiasis).
• Speaking problems – slurred or hoarse speech due to lack of lubrication.
• Dry, cracked lips and a feeling of “sticky” mouth.
• Bad breath (halitosis) caused by bacterial overgrowth.
• Sleep disturbances from chronic throat dryness.

When to See a Doctor

Although xerostomia is often manageable at home, certain signs warrant prompt professional evaluation:

• Persistent pain or burning sensation in the mouth (oral burning syndrome).
• Visible white patches, sores, or persistent redness that do not improve within a week.
• Repeated episodes of oral infections, especially thrush.
• Rapidly increasing dental decay despite regular brushing and fluoride use.
• Difficulty swallowing liquids or a sensation of food getting “stuck.”
• Unexplained weight loss or dehydration.
• Any new or worsening symptom during or after radiation treatment.

Early assessment helps prevent complications that could affect nutrition, speech, and overall treatment outcomes.

Diagnosis

Diagnosis of radiation‑related xerostomia combines a clinical interview, objective testing, and sometimes imaging:

1. Clinical History

The clinician will ask about the radiation dose, fields treated, timing of symptoms, medication list, and oral hygiene practices.

2. Salivary Flow Measurement

• Unstimulated whole‑saliva flow – patient spits into a graduated container for 5 minutes; < 0.1 mL/min is considered severely reduced.
• Stimulated flow – chewing paraffin wax or citric acid stimulates saliva; values < 0.5 mL/min indicate dysfunction.

3. Sialometry & Sialochemistry

Analyzing saliva composition (pH, electrolytes, amylase) can help differentiate medication‑induced from radiation‑induced xerostomia.

4. Imaging

• Ultrasound or MRI – evaluates gland size and fibrosis.
• Sialoscintigraphy (radioisotope scan) – shows functional uptake by the glands.

5. Oral Examination

The dentist or oral surgeon looks for caries, mucosal lesions, fungal overgrowth, and assesses the integrity of the teeth and prostheses.

Treatment Options

Treatment is multimodal, aiming to improve saliva production, protect oral tissues, and alleviate discomfort.

Medical Interventions

• Salivary substitutes – over‑the‑counter mouth rinses (e.g., Biotène), sprays, or gels that mimic saliva’s lubricating properties.
• Saliva stimulants – sugar‑free chewing gums or lozenges containing xylitol; prescription agents such as pilocarpine (Salagen) or cevimeline (Evoxac) that activate muscarinic receptors to increase flow.
• Amifostine – a radioprotective drug sometimes administered before radiation to preserve gland function; its use is limited by nausea and hypotension.
• Antifungal therapy – topical nystatin or systemic fluconazole for candidiasis.
• Fluoride varnish or high‑fluoride toothpaste – reduces the risk of radiation‑related caries (recommended by the CDC).
• Systemic hydration – encouraging adequate fluid intake (at least 2–3 L/day unless contraindicated).

Home & Lifestyle Strategies

• Sip water or sugar‑free electrolyte solutions throughout the day; avoid caffeine and alcohol which are diuretics.
• Use a humidifier at night to keep oral mucosa moist.
• Chew sugar‑free gum or suck on xylitol lozenges after meals to stimulate residual gland function.
• Maintain meticulous oral hygiene: brush twice daily with a soft‑bristled toothbrush, floss, and use fluoride mouth rinses.
• Limit acidic, spicy, and salty foods that can irritate a dry mucosa.
• Avoid tobacco and limit alcohol consumption.
• Consider dietary modifications—soft, moist foods (e.g., soups, smoothies, yogurt) are easier to swallow.

Advanced Therapies (for refractory cases)

• Low‑level laser therapy (LLLT) – some studies suggest it can improve residual salivary flow.
• Botulinum toxin injections – paradoxically, low‑dose injections into the salivary glands can reduce “over‑dryness” by modulating neural input; evidence is emerging.
• Acupuncture – small trials indicate benefit in stimulating salivation.
• Salivary gland transplantation or submandibular gland transfer – surgical options performed before radiation in select high‑risk patients.

Prevention Tips

When radiation therapy is planned, several steps can lessen the risk of xerostomia:

• Advanced radiation techniques – IMRT or proton therapy can spare the parotid glands while delivering curative doses to the tumor.
• Parotid-sparing dose constraints – limiting each parotid gland to ≤26 Gy when feasible reduces long‑term dryness (Guidelines from the NIH).
• Use of radioprotective agents – amifostine given before each fraction.
• Pre‑treatment dental evaluation – eliminating existing caries and managing periodontal disease decreases complications.
• Pre‑emptive saliva stimulants – starting pilocarpine or chewing gum early in the treatment course can preserve residual gland function.
• Hydration and nutrition counseling – dietitians can plan moist, nutrient‑dense meals.
• Smoking cessation – quitting smoking before radiation improves glandular blood flow.

Emergency Warning Signs

Key Take‑aways

• Radiation therapy to the head and neck frequently damages salivary glands, leading to xerostomia.
• Dry mouth compromises chewing, swallowing, speech, and dental health; early detection is essential.
• Diagnosis includes history, sialometry, and sometimes imaging.
• Treatment combines saliva substitutes, pharmacologic stimulants, meticulous oral care, and lifestyle modifications.
• Prevention focuses on modern radiation techniques, radioprotective drugs, and proactive dental care.
• Contact a health professional promptly for pain, infection, swallowing difficulty, or any red‑flag symptom.

For more information, please consult reputable sources such as the Mayo Clinic, CDC, NIH, and the World Health Organization. Your oncology team, dental professional, and speech‑language pathologist are valuable allies in managing xerostomia and maintaining quality of life during and after radiation therapy.